Brazil’s Parana state is in talks to produce a COVID-19 vaccine approved by Russia despite not having completed mass clinical trials, but it was unclear if the state’s research institute would get regulatory approval in Brazil.
Brazilian billionaire Jorge Lemann's foundation and other business interests will fund the building of the factory to produce the Covid-19 vaccine being developed by Oxford University and pharmaceutical company AstraZeneca.
Brazilian officials say they can start making COVID-19 vaccines developed by British and Chinese researchers within a year. Experts say it will take at least twice as long, leaving Brazil reliant on imports to slow the world's second-worst outbreak.
The World Health Organization (WHO) warned on Monday that, despite strong hopes for a vaccine, there might never be a silver bullet for COVID-19. More than 18.14 million people around the world are reported to have been infected with the disease and 688,080 have died.
Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major COVID-19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks, the Brazilian partners said on Wednesday.
The United States has doubled its investment - to nearly US$1 billion - to expedite the development of a potential COVID-19 vaccine by American firm Moderna, which on Monday begins the decisive final phase of clinical trials.
Researchers are making good progress in developing vaccines against COVID-19, with a handful in late-stage trials, but their first use cannot be expected until early 2021, a World Health Organization (WHO) expert said on Wednesday.
By Rebecca Ashfiled (*) – A vaccine against COVID-19 is urgently needed if we’re to stop the virus spreading and prevent potentially millions of further deaths. We’re now one step closer to that goal.
A Chinese-made vaccine against the new COVID-19 entered the final stage of testing on Tuesday in Brazil, where volunteers received the first doses of what officials hope will be a game-changer in the pandemic.
Brazil announced over the weekend that it had signed a US$ 127 million agreement to start producing locally an experimental vaccine developed by AstraZeneca that has shown promise to fight the COVID-19 pandemic.